The Ternary Complex Factor Net Regulates Cell Migration through Inhibition of PAI-1 Expression

REFERENCES

• Ayadi, A., M. Suelves, P. Dolle, and B. Wasylyk. 2001. Net, an Ets ternary complex transcription factor, is expressed in sites of vasculogenesis, angiogenesis, and chondrogenesis during mouse development. Mech. Dev. 102:205–208.
   PubMedGoogle Scholar
• Ayadi, A., H. Zheng, P. Sobieszczuk, G. Buchwalter, P. Moerman, K. Alitalo, and B. Wasylyk. 2001. Net-targeted mutant mice develop a vascular phenotype and up-regulate egr-1. EMBO J. 20:5139–5152.
   PubMedGoogle Scholar
• Bajou, K., C. Maillard, M. Jost, R. H. Lijnen, A. Gils, P. Declerck, P. Carmeliet, J. M. Foidart, and A. Noel. 2004. Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth. Oncogene 23:6986–6990.
   PubMed Web of Science ®Google Scholar
• Bass, R., and V. Ellis. 2002. Cellular mechanisms regulating non-haemostatic plasmin generation. Biochem. Soc. Trans. 30:189–194.
   PubMedGoogle Scholar
• Bauer, S., J. Pollheimer, J. Hartmann, P. Husslein, J. D. Aplin, and M. Knofler. 2004. Tumor necrosis factor-alpha inhibits trophoblast migration through elevation of plasminogen activator inhibitor-1 in first-trimester villous explant cultures. J. Clin. Endocrinol. Metab. 89:812–822.
   PubMed Web of Science ®Google Scholar
• Bijnens, A. P., A. Gils, I. Knockaert, J. M. Stassen, and P. J. Declerck. 2000. Importance of the hinge region between alpha-helix F and the main part of serpins, based upon identification of the epitope of plasminogen activator inhibitor type 1 neutralizing antibodies. J. Biol. Chem. 275:6375–6380.
   PubMedGoogle Scholar
• Brooks, T. D., J. Slomp, P. H. Quax, A. C. De Bart, M. T. Spencer, J. H. Verheijen, and P. A. Charlton. 2000. Antibodies to PAI-1 alter the invasive and migratory properties of human tumour cells in vitro. Clin. Exp. Metastasis 18:445–453.
   PubMed Web of Science ®Google Scholar
• Buchwalter, G., C. Gross, and B. Wasylyk. 2004. Ets ternary complex transcription factors. Gene 324:1–14.
   PubMed Web of Science ®Google Scholar
• Carmeliet, P., L. Moons, R. Lijnen, S. Janssens, F. Lupu, D. Collen, and R. D. Gerard. 1997. Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: a gene targeting and gene transfer study in mice. Circulation 96:3180–3191.
   PubMed Web of Science ®Google Scholar
• Cesari, F., S. Brecht, K. Vintersten, L. G. Vuong, M. Hofmann, K. Klingel, J. J. Schnorr, S. Arsenian, H. Schild, T. Herdegen, F. F. Wiebel, and A. Nordheim. 2004. Mice deficient for the ets transcription factor Elk-1 show normal immune responses and mildly impaired neuronal gene activation. Mol. Cell. Biol. 24:294–305.
   PubMedGoogle Scholar
• Chan, J. C., D. A. Duszczyszyn, F. J. Castellino, and V. A. Ploplis. 2001. Accelerated skin wound healing in plasminogen activator inhibitor-1-deficient mice. Am. J. Pathol. 159:1681–1688.
   PubMed Web of Science ®Google Scholar
• Chen, Y. Q., M. Su, R. R. Walia, Q. Hao, J. W. Covington, and D. E. Vaughan. 1998. Sp1 sites mediate activation of the plasminogen activator inhibitor-1 promoter by glucose in vascular smooth muscle cells. J. Biol. Chem. 273:8225–8231.
   PubMed Web of Science ®Google Scholar
• Chorostowska-Wynimko, J., E. Skrzypczak-Jankun, and J. Jankun. 2004. Plasminogen activator inhibitor type-1: its structure, biological activity and role in tumorigenesis (review). Int. J. Mol. Med. 13:759–766.
   PubMed Web of Science ®Google Scholar
• Costello, P. S., R. H. Nicolas, Y. Watanabe, I. Rosewell, and R. Treisman. 2004. Ternary complex factor SAP-1 is required for Erk-mediated thymocyte positive selection. Nat. Immunol. 5:289–298.
   PubMedGoogle Scholar
• Criqui-Filipe, P., C. Ducret, S. M. Maira, and B. Wasylyk. 1999. Net, a negative Ras-switchable TCF, contains a second inhibition domain, the CID, that mediates repression through interactions with CtBP and de-acetylation. EMBO J. 18:3392–3403.
   PubMedGoogle Scholar
• Datta, P. K., M. C. Blake, and H. L. Moses. 2000. Regulation of plasminogen activator inhibitor-1 expression by transforming growth factor-beta-induced physical and functional interactions between smads and Sp1. J. Biol. Chem. 275:40014–40019.
   PubMed Web of Science ®Google Scholar
• Debrock, S., and P. J. Declerck. 1997. Neutralization of plasminogen activator inhibitor-1 inhibitory properties: identification of two different mechanisms. Biochim. Biophys. Acta 1337:257–266.
   PubMedGoogle Scholar
• Dennler, S., S. Itoh, D. Vivien, P. ten Dijke, S. Huet, and J. M. Gauthier. 1998. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 17:3091–3100.
   PubMed Web of Science ®Google Scholar
• Devy, L., S. Blacher, C. Grignet-Debrus, K. Bajou, V. Masson, R. D. Gerard, A. Gils, G. Carmeliet, P. Carmeliet, P. J. Declerck, A. Noel, and J. M. Foidart. 2002. The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent. FASEB J. 16:147–154.
   PubMedGoogle Scholar
• Dittmer, J., and A. Nordheim. 1998. Ets transcription factors and human disease. Biochim. Biophys. Acta 1377:F1–11.
   PubMedGoogle Scholar
• Elbashir, S. M., J. Harborth, W. Lendeckel, A. Yalcin, K. Weber, and T. Tuschl. 2001. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494–498.
   PubMed Web of Science ®Google Scholar
• Fitzsimmons, D., W. Hodsdon, W. Wheat, S. M. Maira, B. Wasylyk, and J. Hagman. 1996. Pax-5 (BSAP) recruits Ets proto-oncogene family proteins to form functional ternary complexes on a B-cell-specific promoter. Genes Dev. 10:2198–2211.
   PubMedGoogle Scholar
• Giovane, A., A. Pintzas, S. M. Maira, P. Sobieszczuk, and B. Wasylyk. 1994. Net, a new ets transcription factor that is activated by Ras. Genes Dev. 8:1502–1513.
   PubMed Web of Science ®Google Scholar
• Hjortland, G. O., K. Bjornland, S. Pettersen, S. S. Garman-Vik, E. Emilsen, J. M. Nesland, O. Fodstad, and O. Engebraaten. 2003. Modulation of glioma cell invasion and motility by adenoviral gene transfer of PAI-1. Clin. Exp. Metastasis 20:301–309.
   PubMedGoogle Scholar
• Juhan-Vague, I., M. C. Alessi, A. Mavri, and P. E. Morange. 2003. Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk. J. Thromb. Haemost. 1:1575–1579.
   PubMed Web of Science ®Google Scholar
• Kanse, S. M., C. Kost, O. G. Wilhelm, P. A. Andreasen, and K. T. Preissner. 1996. The urokinase receptor is a major vitronectin-binding protein on endothelial cells. Exp. Cell Res. 224:344–353.
   PubMed Web of Science ®Google Scholar
• Kietzmann, T., U. Roth, and K. Jungermann. 1999. Induction of the plasminogen activator inhibitor-1 gene expression by mild hypoxia via a hypoxia response element binding the hypoxia-inducible factor-1 in rat hepatocytes. Blood 94:4177–4185.
   PubMed Web of Science ®Google Scholar
• Latinkic, B. V., M. Zeremski, and L. F. Lau. 1996. Elk-1 can recruit SRF to form a ternary complex upon the serum response element. Nucleic Acids Res. 24:1345–1351.
   PubMed Web of Science ®Google Scholar
• Li, F., J. Goncalves, K. Faughnan, M. G. Steiner, I. Pagan-Charry, D. Esposito, B. Chin, K. M. Providence, P. J. Higgins, and L. Staiano-Coico. 2000. Targeted inhibition of wound-induced PAI-1 expression alters migration and differentiation in human epidermal keratinocytes. Exp. Cell Res. 258:245–253.
   PubMedGoogle Scholar
• Li, Q. J., S. Vaingankar, F. M. Sladek, and M. Martins-Green. 2000. Novel nuclear target for thrombin: activation of the Elk1 transcription factor leads to chemokine gene expression. Blood 96:3696–3706.
   PubMedGoogle Scholar
• Lorena, D., K. Uchio, A. M. Costa, and A. Desmouliere. 2002. Normal scarring: importance of myofibroblasts. Wound Repair Regen. 10:86–92.
   PubMedGoogle Scholar
• Lund, L. R. 1996. Expression of urokinase-type plasminogen activator, its receptor and type-1 plasminogen activator inhibitor is differently regulated by inhibitors of protein synthesis in human cancer cell lines. FEBS Lett. 383:139–144.
   PubMedGoogle Scholar
• Ma, D., R. D. Gerard, X. Y. Li, H. Alizadeh, and J. Y. Niederkorn. 1997. Inhibition of metastasis of intraocular melanomas by adenovirus-mediated gene transfer of plasminogen activator inhibitor type 1 (PAI-1) in an athymic mouse model. Blood 90:2738–2746.
   PubMed Web of Science ®Google Scholar
• Maira, S. M., J. M. Wurtz, and B. Wasylyk. 1996. Net (ERP/SAP2) one of the Ras-inducible TCFs, has a novel inhibitory domain with resemblance to the helix-loop-helix motif. EMBO J. 15:5849–5865.
   PubMedGoogle Scholar
• Martin, P. 1997. Wound healing—aiming for perfect skin regeneration. Science 276:75–81.
   PubMed Web of Science ®Google Scholar
• Motojima, M., T. Ando, and T. Yoshioka. 2000. Sp1-like activity mediates angiotensin-II-induced plasminogen-activator inhibitor type-1 (PAI-1) gene expression in mesangial cells. Biochem. J. 349:435–441.
   PubMedGoogle Scholar
• Palmieri, D., J. W. Lee, R. L. Juliano, and F. C. Church. 2002. Plasminogen activator inhibitor-1 and -3 increase cell adhesion and motility of MDA-MB-435 breast cancer cells. J. Biol. Chem. 277:40950–40957.
   PubMed Web of Science ®Google Scholar
• Praus, M., D. Collen, and R. D. Gerard. 2002. Both u-PA inhibition and vitronectin binding by plasminogen activator inhibitor 1 regulate HT1080 fibrosarcoma cell metastasis. Int. J. Cancer 102:584–591.
   PubMed Web of Science ®Google Scholar
• Praus, M., K. Wauterickx, D. Collen, and R. D. Gerard. 1999. Reduction of tumor cell migration and metastasis by adenoviral gene transfer of plasminogen activator inhibitors. Gene Ther. 6:227–236.
   PubMed Web of Science ®Google Scholar
• Providence, K. M., and P. J. Higgins. 2004. PAI-1 expression is required for epithelial cell migration in two distinct phases of in vitro wound repair. J. Cell Physiol. 200:297–308.
   PubMedGoogle Scholar
• Providence, K. M., S. M. Kutz, L. Staiano-Coico, and P. J. Higgins. 2000. PAI-1 gene expression is regionally induced in wounded epithelial cell monolayers and required for injury repair. J. Cell Physiol. 182:269–280.
   PubMedGoogle Scholar
• Quandt, K., K. Frech, H. Karas, E. Wingender, and T. Werner. 1995. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 23:4878–4884.
   PubMed Web of Science ®Google Scholar
• Roca, C., L. Primo, D. Valdembri, A. Cividalli, P. Declerck, P. Carmeliet, P. Gabriele, and F. Bussolino. 2003. Hyperthermia inhibits angiogenesis by a plasminogen activator inhibitor 1-dependent mechanism. Cancer Res. 63:1500–1507.
   PubMed Web of Science ®Google Scholar
• Samarakoon, R., and P. J. Higgins. 2002. MEK/ERK pathway mediates cell-shape-dependent plasminogen activator inhibitor type 1 gene expression upon drug-induced disruption of the microfilament and microtubule networks. J. Cell Sci. 115:3093–3103.
   PubMed Web of Science ®Google Scholar
• Schleef, R. R., and D. J. Loskutoff. 1988. Fibrinolytic system of vascular endothelial cells. Role of plasminogen activator inhibitors. Haemostasis 18:328–341.
   PubMedGoogle Scholar
• Schratt, G., U. Philippar, J. Berger, H. Schwarz, O. Heidenreich, and A. Nordheim. 2002. Serum response factor is crucial for actin cytoskeletal organization and focal adhesion assembly in embryonic stem cells. J. Cell Biol. 156:737–750.
   PubMedGoogle Scholar
• Seite, S., A. Colige, C. Deroanne, C. Lambert, P. Piquemal-Vivenot, C. Montastier, A. Fourtanier, C. Lapiere, and B. Nusgens. 2004. Changes in matrix gene and protein expressions after single or repeated exposure to one minimal erythemal dose of solar-simulated radiation in human skin in vivo. Photochem. Photobiol. 79:265–271.
   PubMedGoogle Scholar
• Sharrocks, A. D. 2002. Complexities in ETS-domain transcription factor function and regulation: lessons from the TCF (ternary complex factor) subfamily. The Colworth Medal Lecture. Biochem. Soc. Trans. 30:1–9.
   PubMed Web of Science ®Google Scholar
• Sharrocks, A. D. 2001. The ETS-domain transcription factor family. Nat Rev. Mol. Cell Biol. 2:827–837.
   PubMed Web of Science ®Google Scholar
• Shaw, P. E., and J. Saxton. 2003. Ternary complex factors: prime nuclear targets for mitogen-activated protein kinases. Int. J. Biochem. Cell Biol. 35:1210–1226.
   PubMed Web of Science ®Google Scholar
• Spadari, S., F. Focher, C. Kuenzle, E. J. Corey, A. G. Myers, N. Hardt, A. Rebuzzini, G. Ciarrocchi, and G. Pedrali-Noy. 1985. In vivo distribution and activity of aphidicolin on dividing and quiescent cells. Antiviral Res. 5:93–101.
   PubMedGoogle Scholar
• Stefansson, S., and D. A. Lawrence. 1996. The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin. Nature 383:441–443.
   PubMed Web of Science ®Google Scholar
• Stefansson, S., G. A. McMahon, E. Petitclerc, and D. A. Lawrence. 2003. Plasminogen activator inhibitor-1 in tumor growth, angiogenesis and vascular remodeling. Curr. Pharm. Des. 9:1545–1564.
   PubMed Web of Science ®Google Scholar
• Treisman, R. 1995. Journey to the surface of the cell: Fos regulation and the SRE. EMBO J. 14:4905–4913.
   PubMedGoogle Scholar
• Treisman, R. 1996. Regulation of transcription by MAP kinase cascades. Curr. Opin. Cell Biol. 8:205–215.
   PubMed Web of Science ®Google Scholar
• Treisman, R. 1992. The serum response element. Trends Biochem. Sci. 17:423–426.
   PubMed Web of Science ®Google Scholar
• Treisman, R., R. Marais, and J. Wynne. 1992. Spatial flexibility in ternary complexes between SRF and its accessory proteins. EMBO J. 11:4631–4640.
   PubMedGoogle Scholar
• Tsai, E. Y., J. V. Falvo, A. V. Tsytsykova, A. K. Barczak, A. M. Reimold, L. H. Glimcher, M. J. Fenton, D. C. Gordon, I. F. Dunn, and A. E. Goldfeld. 2000. A lipopolysaccharide-specific enhancer complex involving Ets, Elk-1, Sp1, and CREB binding protein and p300 is recruited to the tumor necrosis factor alpha promoter in vivo. Mol. Cell. Biol. 20:6084–6094.
   PubMed Web of Science ®Google Scholar
• van Riggelen, J., G. Buchwalter, U. Soto, J. De-Castro Arce, H. Z. Hausen, B. Wasylyk, and F. Rosl. 2005. Loss of net as repressor leads to constitutive increased c-fos transcription in cervical cancer cells. J. Biol. Chem. 280:3286–3294.
   PubMedGoogle Scholar
• Verger, A., and M. Duterque-Coquillaud. 2002. When Ets transcription factors meet their partners. Bioessays 24:362–370.
   PubMed Web of Science ®Google Scholar
• Vulin, A. I., and F. M. Stanley. 2002. A Forkhead/winged helix-related transcription factor mediates insulin-increased plasminogen activator inhibitor-1 gene transcription. J. Biol. Chem. 277:20169–20176.
   PubMedGoogle Scholar
• Wasylyk, C., P. Criqui-Filipe, and B. Wasylyk. 2005. Sumoylation of the net inhibitory domain (NID) is stimulated by PIAS1 and has a negative effect on the transcriptional activity of Net. Oncogene 24:820–828.
   PubMed Web of Science ®Google Scholar
• Whitley, B. R., D. Palmieri, C. D. Twerdi, and F. C. Church. 2004. Expression of active plasminogen activator inhibitor-1 reduces cell migration and invasion in breast and gynecological cancer cells. Exp. Cell Res. 296:151–162.
   PubMedGoogle Scholar
• Withers, D. A., and S. I. Hakomori. 2000. Human α(1,3)-fucosyltransferase IV (FUTIV) gene expression is regulated by Elk-1 in the U937 cell line. J. Biol. Chem. 275:40588–40593.
   PubMedGoogle Scholar
• Yamazaki, Y., H. Kubota, M. Nozaki, and K. Nagata. 2003. Transcriptional regulation of the cytosolic chaperonin theta subunit gene, Cctq, by Ets domain transcription factors Elk-1, Sap-1a, and Net in the absence of serum response factor. J. Biol. Chem. 278:30642–30651.
   PubMedGoogle Scholar
• Yang, S. H., and A. D. Sharrocks. 2004. SUMO promotes HDAC-mediated transcriptional repression. Mol. Cell 13:611–617.
   PubMed Web of Science ®Google Scholar
• Yang, S. H., A. D. Sharrocks, and A. J. Whitmarsh. 2003. Transcriptional regulation by the MAP kinase signaling cascades. Gene 320:3–21.
   PubMed Web of Science ®Google Scholar
• Zheng, H., C. Wasylyk, A. Ayadi, J. Abecassis, J. A. Schalken, H. Rogatsch, N. Wernert, S. M. Maira, M. C. Multon, and B. Wasylyk. 2003. The transcription factor Net regulates the angiogenic switch. Genes Dev. 17:2283–2297.
   PubMedGoogle Scholar